Circulating antagonist of luteinizing hormone in association with infertility in stallions.
Abstract: Using a LH radioligand receptor assay (RRA) previously validated for use in serum and an equine monoclonal RIA, we have distinguished a subset of subfertile stallions with an elevated RRA/RIA ratio. After purification of the active moiety by anion exchange chromatography and immunoprecipitation with the equine LH (eLH) monoclonal antibody, RRA activity remained in the supernatant. This activity was also recognized by a polyclonal LH antibody (GDN 15) with wide cross-species recognition. This active fraction was further purified by gel filtration chromatography and shown to displace labeled eLH in a dose-dependent fashion in the RRA with an inhibition slope of 2.8 compared with a slope of 1.1 for native eLH. This fraction also inhibited the LH-stimulated steroidogenesis of Leydig cells in vitro in a dose-dependent fashion, but had no effect on basal (minus LH) steroid production. Polyacrylamide gel electrophoresis and electroelution of this material demonstrated RRA activity in a fraction with a mol wt between 45-66 kDa. We conclude that this substance 1) competitively inhibited binding of eLH and hCG to the LH receptor, 2) antagonized LH-stimulated steroidogenesis in vitro, and 3) may represent a LH isoform found in association with infertility in these animals.
Publication Date: 1991-05-01 PubMed ID: 2019262DOI: 10.1210/endo-128-5-2497Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- Non-U.S. Gov't
- Research Support
- U.S. Gov't
- P.H.S.
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research investigated the association of a luteinizing hormone (LH) antagonist with infertility in stallions, finding that a substance in the blood may prevent LH from binding to its receptor, thereby inhibiting reproductive functions and contributing to infertility.
Methods and Findings
- To find this potentially reproductive-inhibiting substance, the researchers used a radioligand receptor assay (RRA) and a monoclonal radioimmunoassay (RIA) that are known to work in serum. This led them to identify a group of less fertile stallions that had a higher RRA to RIA ratio than usual.
- The scientists isolated the active part of the substance using anion exchange chromatography and immunoprecipitation with the equine luteinizing hormone (eLH) monoclonal antibody. Even after these purification steps, RRA activity remained, which suggests that the active part of the substance may be one that blocks the binding of the hormone to its receptor.
- The purified active fraction was recognized by a polyclonal LH antibody with broad cross-species recognition, indicating that the substance may interact with the LH receptor in a similar way across different species.
- This fraction was further purified and shown to block labeled eLH from binding to its receptor in a dose-dependent manner in the RRA. The fraction also inhibited LH-stimulated steroidogenesis – the production of steroids that is essential to the reproductive function – in Leydig cells in vitro in a dose-dependent manner.
- However, the substance doesn’t impact basal steroid production, which means it only affects steroidogenesis when LH is present.
- The researchers then ran polyacrylamide gel electrophoresis and electroelution, two techniques used to analyze proteins, on the substance. This revealed that the molecule had a weight ranging from 45-66 kDa, suggesting that it may be a protein or peptide.
Conclusion
- From their findings, the researchers concluded that this substance blocks the binding of eLH and human chorionic gonadotropin (hCG), another hormone important for reproduction, to the LH receptor.
- It also inhibits LH’s ability to stimulate steroidogenesis, which is crucial for reproductive processes.
- The substance may be a form of LH that is found in infertile stallions, suggesting a possible link between this substance and infertility in these animals.
Cite This Article
APA
Whitcomb RW, Schneyer AL, Roser JF, Hughes JP.
(1991).
Circulating antagonist of luteinizing hormone in association with infertility in stallions.
Endocrinology, 128(5), 2497-2502.
https://doi.org/10.1210/endo-128-5-2497 Publication
Researcher Affiliations
- Department of Medicine, Massachusetts General Hospital, Boston 02114.
MeSH Terms
- Animals
- Binding, Competitive
- Biological Assay
- Cell Line
- Electrophoresis, Polyacrylamide Gel
- Horse Diseases / blood
- Horses / blood
- Infertility / blood
- Infertility / veterinary
- Leydig Cells / metabolism
- Luteinizing Hormone / antagonists & inhibitors
- Luteinizing Hormone / blood
- Male
- Molecular Weight
- Radioimmunoassay
- Radioligand Assay
Grant Funding
- FD-U-000523-1 / FDA HHS
- HD-15788 / NICHD NIH HHS
- HD-25941 / NICHD NIH HHS
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists